New Enterprise Associates 13 Lp Phase Bio Pharmaceuticals Inc (PHAS) insider trading activity

New Enterprise Associates 13 LP is > 10% Shareholder of PhaseBio Pharmaceuticals Inc. Currently has a direct ownership of 4.86 Million shares of PHAS, which is worth approximately $0. The most recent transaction as insider was on Oct 25, 2022, when has been sold 1,784,109 shares (Common Stock) at a price of $0.15 per share, resulting in proceeds of $267,616. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 4.86M

0% 3M change

0% 12M change

Total Value Held $0

NEW ENTERPRISE ASSOCIATES 13 LP Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Oct 25 2022	SELL Open market or private sale	$267,616 $0.15 p/Share	1,784,109 Reduced 26.86%	4,857,525 Common Stock

Also insider at

NET

Cloudflare, Inc. Technology

> 10% Shareholder

SPT

Sprout Social, Inc. Technology

> 10% Shareholder

COUR

Coursera, Inc. Consumer Defensive

> 10% Shareholder

UTRS

MINERVA SURGICAL INC Healthcare

> 10% Shareholder

SGMT

Sagimet Biosciences Inc.

> 10% Shareholder

NEA